{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Feuas-whats-available-inpatient-part-2-YoIT87ep","width":444,"version":"1.0","type":"rich","title":"EUAs: What’s Available Inpatient? Part 2","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/947d3b7f-3890-4e80-8529-6486b02916d4/8dbae7e6-e38b-4441-82f7-339a1ec5720f/covid-podcast-euas-whats-available-inpatient-part-2-episode3.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3239cda3-e70b-4ec4-aa77-10d29a195ce3\" height=\"200\" width=\"100%\" title=\"EUAs: What’s Available Inpatient? Part 2\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this second half of a discussion about treatments for COVID-19 in the hospital setting, an expert explains the use of dexamethasone, including insights on the choice of steroids to treat COVID-19 in pregnancy. The conversation then moves to other immune modulators, tocilizumab and the combination of baricitinib plus the antiviral remdesivir, and includes an overview of the evidence on efficacy and safety.Claim your credit at pce.is/COV19."}